GTEC Holdings Ltd. (TSXV:GTEC) (OTCQB:GGTTF) (FRA:1BUP) (“GTEC” or the “Company”), a vertically integrated premium cannabis producer, is pleased to announce that it has appointed Jurgen Schreiber, the former CEO of Shoppers Drug Mart and former Chairman of ALDO, to its Board of Directors as of June 10, 2019.

Mr. Schreiber joins the Board of GTEC following an extensive and successful career building large multinational retail organizations primarily focused on health & wellness. Mr. Schreiber brings significant expertise and business acumen from various industries to assist in the growth of GTEC. His current and previous roles include the following:


  • Chief Executive Officer at Katz Group (current)
  • Chief Executive Officer at Shoppers Drug Mart
  • Chairman of the Board at ALDO Group
  • Chief Executive Officer at Rexall Health
  • Chief Executive Officer at Health and Beauty Europe (A.S. Watson)
  • Independent Non-Executive Director at Thomas Cook Group (current)

“The management team and Board of Directors at GTEC are extremely excited to have Jurgen join the organization,” said Norton Singhavon, GTEC Founder, Chairman and CEO. “Jurgen’s operational experience and driving force behind large Canadian and international organizations will add significant value, guidance and leadership as we continue to execute on our plans to produce, market and distribute ultra-premium cannabis and its derivatives in Canada.”

“I am extremely delighted to join the Board of Directors of GTEC and work together with the management team to make this inspiring company even stronger,” said Jurgen Schreiber. “The alignment with the vision and strategy made this decision easy. We want to build this company together, into a strong force for our customers and all our stakeholders.”

Effective immediately, the Board of Directors at GTEC will be comprised of the following members:

Norton Singhavon
Founder, Chairman and CEO at GTEC
Chairman of the Board

Michael Blady
Co-Founder, Vice President at GTEC
Director

Jurgen Schreiber
CEO at Katz Group
Independent non-executive director

Aaron Dow
Partner at Farris, Vaughan, Wills & Murphy LLP
Independent non-executive director
Chair of the Compensation Committee

Derek Sanders CA, CBV, CFA
Partner at SVG Capital Group
Independent non-executive director
Chair of the Audit Committee

Mr. Schreiber is a highly accomplished executive with deep experience in the global retail pharmacy, health, beauty sectors and Fast-Moving Consumer Goods (FMCG) business.  He has significant experience in the FMCG and multinational retail industry, including several senior leadership positions with Reckitt Benckiser,  CEO of Health and Beauty Europe, at A.S. Watson where he was responsible for 4000 stores in 23 countries, CEO and President of Shoppers Drug Mart (Pharmaprix in Quebec), CEO and President of Rexall Health, and most recently as CEO at Katz Group. He also served as the Chairman of the Board and Member at ALDO Group from 2017 to 2019, and previous to that, lead the Advisory Board from 2013 to 2017.

About GTEC

GTEC Holdings is a specialized cannabis company dedicated to cultivating ultra-premium quality cannabis in purpose-built indoor facilities. The company is vertically integrated across all major sectors of the Canadian cannabis industry and is currently licensed by Health Canada for Standard Cultivation, Standard Processing and Analytical testing. The management team is comprised of a diverse skill set sourced from leading global food & beverage and premium alcohol companies. GTEC has completed three cultivation facilities and is currently cultivating and selling cannabis.

The Company has two additional facilities coming on stream in the latter half of 2019, which will increase annual capacity from 4,000 kg to 14,000 kg. GTEC’s retail division is pursuing licensing for over 35 recreational cannabis stores across Western Canada. GTEC’s ultra-premium indoor flower will be marketed and sold under its flagship trademarked brands; BLK MKT™, Tenzo™, GreenTec™, Cognōscente™, Treehugger™, and FN™.

GTEC is actively pursuing sales and distribution opportunities across all major business channels: medical, recreational, B2B and export. GTEC is a publicly traded corporation, listed on the TSX Venture Exchange, OTCQB Venture Market and Frankfurt Stock Exchange. The Company is headquartered in Kelowna, British Columbia.

To view more about the company or to request our most recent corporate presentation, please visit our website at www.gtec.co

On behalf of the board,

Norton Singhavon
Founder, Chairman & CEO

Michael Blady
Co-Founder & Vice President
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals, where applicable and the state of the capital markets. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Click here to connect with GTEC Holdings Ltd. (TSXV:GTEC) (OTC:GGTTF) for an Investor Presentation.

Source: www.globenewswire.com

Thoughtful Brands, Inc. (CSE:TBI)(FWB:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands“), an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe, announces that it intends to consolidate its issued and outstanding common shares (“Shares”) at a ratio of ten (10) pre-consolidated Shares to one (1) post-consolidation Share (the “Consolidation

The Company currently has 389,274,701 Shares issued and outstanding. Following the Consolidation there will be approximately 38,927,470 Shares issued and outstanding. No fractional Shares will be issued and any fractions of a Share will be rounded down to the nearest whole number of Shares. The exercise or conversion price and the number of Shares issuable under any of the Company’s outstanding convertible securities will be proportionately adjusted upon Consolidation.

Keep reading... Show less

In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.

Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.

Keep reading... Show less

The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Keep reading... Show less

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising

Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.

In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.

Keep reading... Show less